Streamlining TARE or personalizing SIRT? Different philosophies to treat different HCCs with Yttrium-90 …

The use of Yttrium-90 microspheres in liver malignancies is known by two names: selective internal radiation therapy (SIRT) and transarterial radioembolization (TARE). Interestingly, the two names reflect two representations of the therapy, and might be a reason why the role of SIRT in the field of hepatocellular carcinoma (HCC) treatment is still not clear in the mind of many clinicians. While some guidelines (i.e. EASL's) do not recommend its use, others (i.e. ESMO's) do recognize some space in the therapeutic armamentarium.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Editorial Source Type: research